Shanahan WR Jr - Search Results

1

ISIS 2302, an antisense inhibitor of intercellular adhesion molecule 1.

Shanahan WR Jr. Shanahan WR Jr. Expert Opin Investig Drugs. 1999 Sep;8(9):1417-29. doi: 10.1517/13543784.8.9.1417. Expert Opin Investig Drugs. 1999. PMID: 15992159

2

Phase I and phase II safety and efficacy trial of intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302) for the prevention of acute allograft rejection.

Kahan BD, Stepkowski S, Kilic M, Katz SM, Van Buren CT, Welsh MS, Tami JA, Shanahan WR Jr. Kahan BD, et al. Among authors: shanahan wr jr. Transplantation. 2004 Sep 27;78(6):858-63. doi: 10.1097/01.tp.0000128857.77893.d2. Transplantation. 2004. PMID: 15385805 Clinical Trial.

3

New approaches for the treatment of anaphylaxis.

Leung DY, Shanahan WR Jr, Li XM, Sampson HA. Leung DY, et al. Among authors: shanahan wr jr. Novartis Found Symp. 2004;257:248-60; discussion 260-4, 276-85. Novartis Found Symp. 2004. PMID: 15025403 Clinical Trial.

4

Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1.

Kuritzkes DR, Jacobson J, Powderly WG, Godofsky E, DeJesus E, Haas F, Reimann KA, Larson JL, Yarbough PO, Curt V, Shanahan WR Jr. Kuritzkes DR, et al. Among authors: shanahan wr jr. J Infect Dis. 2004 Jan 15;189(2):286-91. doi: 10.1086/380802. Epub 2004 Jan 8. J Infect Dis. 2004. PMID: 14722894

5

Response to "effect of anti-IgE therapy in patients with food allergy".

Leung DY, Shanahan WR Jr, Sampson HA. Leung DY, et al. Among authors: shanahan wr jr. Ann Allergy Asthma Immunol. 2003 Dec;91(6):515-7. doi: 10.1016/S1081-1206(10)61527-X. Ann Allergy Asthma Immunol. 2003. PMID: 14700433 No abstract available.

6

Effect of anti-IgE therapy in patients with peanut allergy.

Leung DY, Sampson HA, Yunginger JW, Burks AW Jr, Schneider LC, Wortel CH, Davis FM, Hyun JD, Shanahan WR Jr; Avon Longitudinal Study of Parents and Children Study Team. Leung DY, et al. Among authors: shanahan wr jr. N Engl J Med. 2003 Mar 13;348(11):986-93. doi: 10.1056/NEJMoa022613. Epub 2003 Mar 10. N Engl J Med. 2003. PMID: 12637608 Free article. Clinical Trial.

7

A randomized, placebo controlled trial of an antisense oligodeoxynucleotide to intercellular adhesion molecule-1 in the treatment of severe rheumatoid arthritis.

Maksymowych WP, Blackburn WD Jr, Tami JA, Shanahan WR Jr. Maksymowych WP, et al. Among authors: shanahan wr jr. J Rheumatol. 2002 Mar;29(3):447-53. J Rheumatol. 2002. PMID: 11908555 Clinical Trial.

8

Making sense of antisense.

Yacyshyn BR, Shanahan WR Jr. Yacyshyn BR, et al. Among authors: shanahan wr jr. Can J Gastroenterol. 1999 Nov;13(9):745-51. doi: 10.1155/1999/154140. Can J Gastroenterol. 1999. PMID: 10633827 Review.

9

Preclinical and clinical pharmacology of antisense oligonucleotides.

Marcusson EG, Yacyshyn BR, Shanahan WR Jr, Dean NM. Marcusson EG, et al. Among authors: shanahan wr jr. Mol Biotechnol. 1999 Aug;12(1):1-11. doi: 10.1385/MB:12:1:1. Mol Biotechnol. 1999. PMID: 10554769 Review.

10

A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease.

Yacyshyn BR, Bowen-Yacyshyn MB, Jewell L, Tami JA, Bennett CF, Kisner DL, Shanahan WR Jr. Yacyshyn BR, et al. Among authors: shanahan wr jr. Gastroenterology. 1998 Jun;114(6):1133-42. doi: 10.1016/s0016-5085(98)70418-4. Gastroenterology. 1998. PMID: 9609749 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters